|
4
|
21
|
9zdlA |
A6-a11 diselenide glargine insulin |
|
5
|
32
|
9zdlB |
A6-a11 diselenide glargine insulin |
|
8
|
29
|
9utkB |
Monoclinic crystal structure of acid-stable protracted insulin (293 k) |
|
4
|
21
|
9utkA |
Monoclinic crystal structure of acid-stable protracted insulin (293 k) |
|
8
|
29
|
9utjB |
Monoclinic crystal structure of acid-stable protracted insulin |
|
4
|
21
|
9utjA |
Monoclinic crystal structure of acid-stable protracted insulin |
|
5
|
21
|
9qldA |
Rhombohedral crystalline form of human insulin complexed with m-nitrophenol |
|
8
|
28
|
9qldB |
Rhombohedral crystalline form of human insulin complexed with m-nitrophenol |
|
8
|
27
|
9ibbB |
Rhombohedral crystalline form of human insulin complexed with m-cresol |
|
4
|
21
|
9ibbA |
Rhombohedral crystalline form of human insulin complexed with m-cresol |
|
8
|
29
|
25hlB |
Sfx crystal structure of insulin detemir |
|
9
|
29
|
25hfB |
Sfx crystal structure of insulin aspart |
|
5
|
21
|
25hfA |
Sfx crystal structure of insulin aspart |
|
5
|
21
|
25hlA |
Sfx crystal structure of insulin detemir |
|
6
|
30
|
9r4cB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (500 ms soaking) |
|
4
|
21
|
9r4bA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (250 ms soaking) |
|
5
|
21
|
9r4aA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (50 ms soaking) |
|
5
|
21
|
9r49A |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (25 ms soaking) |
|
6
|
30
|
9r49B |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (25 ms soaking) |
|
6
|
30
|
9r48B |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 9.0 (apo state) |
|
4
|
21
|
9r4eA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (5 s soaking) |
|
6
|
30
|
9r4aB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (50 ms soaking) |
|
4
|
21
|
9r4cA |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (500 ms soaking) |
|
6
|
21
|
9r48A |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 9.0 (apo state) |
|
7
|
30
|
9r4bB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (250 ms soaking) |
|
6
|
30
|
9r4eB |
Spitrobot-2 advances time-resolvedcryo-trapping crystallography to under 25 ms: human insulin, ph 4.5 (5 s soaking) |
|
0
|
21
|
8rvtA |
Structure of full-length human insulin fibrils |
|
0
|
21
|
8rvtB |
Structure of full-length human insulin fibrils |
|
5
|
21
|
9m4yA |
Cubic insulin crystal, esrapid, at ph 3 |
|
4
|
21
|
9lveA |
Temperature induces a shift from the dihexamer to the hexamer form of insulin (300k) |
|
5
|
21
|
9lvxA |
Di-hexamer form of insulin detemir at ambient temperature |
|
7
|
29
|
9m4zB |
Cubic insulin crystal, esrapid, at ph 4 |
|
9
|
29
|
9lveB |
Temperature induces a shift from the dihexamer to the hexamer form of insulin (300k) |
|
4
|
21
|
9lvdA |
Temperature induces a shift from the dihexamer to the hexamer form of insulin (200k) |
|
7
|
29
|
9m51B |
Cubic insulin crystal, esrapid, at ph 6 |
|
7
|
29
|
9m4xB |
Cubic insulin crystal, esrapid, at ph 2 |
|
5
|
21
|
9m4zA |
Cubic insulin crystal, esrapid, at ph 4 |
|
6
|
21
|
9m51A |
Cubic insulin crystal, esrapid, at ph 6 |
|
5
|
21
|
9m4xA |
Cubic insulin crystal, esrapid, at ph 2 |
|
9
|
29
|
9lvcB |
Temperature induces a shift from the dihexamer to the hexamer form of insulin |
|
4
|
21
|
9lvcA |
Temperature induces a shift from the dihexamer to the hexamer form of insulin |
|
7
|
29
|
9m50B |
Cubic insulin crystal, esrapid, at ph 5 |
|
5
|
21
|
9m50A |
Cubic insulin crystal, esrapid, at ph 5 |
|
4
|
21
|
9lvyA |
Hexamer form of insulin detemir at ambient temperature |
|
9
|
29
|
9lvdB |
Temperature induces a shift from the dihexamer to the hexamer form of insulin (200k) |
|
8
|
29
|
9lvxB |
Di-hexamer form of insulin detemir at ambient temperature |
|
9
|
29
|
9lvyB |
Hexamer form of insulin detemir at ambient temperature |
|
7
|
29
|
9m4yB |
Cubic insulin crystal, esrapid, at ph 3 |
|
5
|
21
|
9civA |
X-ray structure of insulin analog detemir |
|
9
|
29
|
9civB |
X-ray structure of insulin analog detemir |
